valerates has been researched along with epidermal growth factor in 3 studies
Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
---|---|---|---|---|---|
2,251 | 294 | 457 | 24,155 | 217 | 4,699 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gibson, PR; Wilson, AJ | 1 |
Benzaria, S; Bhattacharyya, DK; Bienfait, B; Blumberg, PM; Han, KC; Kang, JH; Lee, J; Lewin, NE; Marquez, VE; Nacro, K | 1 |
Himi, T; Kanaizumi, E; Seki, N; Shirasaki, H | 1 |
3 other study(ies) available for valerates and epidermal growth factor
Article | Year |
---|---|
Role of epidermal growth factor receptor in basal and stimulated colonic epithelial cell migration in vitro.
Topics: Acetates; Butyrates; Caco-2 Cells; Cell Movement; Colon; Enzyme Activation; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; Hepatocyte Growth Factor; Humans; Intestinal Mucosa; Mitogens; Propionates; Protein Kinase C; Tetradecanoylphorbol Acetate; Transforming Growth Factor alpha; Valerates | 1999 |
Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?
Topics: 4-Butyrolactone; Antineoplastic Agents; Binding, Competitive; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Enzyme Activation; Epidermal Growth Factor; Isoenzymes; Ligands; Models, Molecular; Protein Kinase C; Protein Kinase C-alpha; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Valerates | 2000 |
Leukotriene E4 induces MUC5AC release from human airway epithelial NCI-H292 cells.
Topics: Adenine; Cell Line; Cells, Cultured; Epidermal Growth Factor; Epithelial Cells; Humans; Interleukin-13; Interleukin-4; Leukotriene E4; Mucin 5AC; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Tretinoin; Valerates | 2015 |